Date published: 2026-4-29

1-800-457-3801

SCBT Portrait Logo
Seach Input

LRRK2 Activators

LRRK2 activators refer to a class of chemical compounds and molecules that have the unique ability to stimulate the activity of the Leucine-rich repeat kinase 2 (LRRK2) protein. LRRK2 is a complex, multi-domain protein found within cells, and it plays a pivotal role in several cellular processes, including vesicle trafficking, cytoskeletal dynamics, and autophagy. Researchers have been keenly interested in understanding the regulatory mechanisms that control LRRK2 activity, as abnormal LRRK2 function has been linked to neurodegenerative disorders, most notably Parkinson's disease. LRRK2 activators, in essence, serve as molecular switches that can 'turn on' LRRK2 kinase activity, which can have implications for cellular homeostasis and various signaling pathways.

Structurally, LRRK2 activators encompass a diverse range of chemical entities. They may be small organic molecules, peptides, or even specific protein fragments. These activators exert their effects by binding to specific regions or domains of the LRRK2 protein, primarily the kinase domain. This binding interaction triggers conformational changes in LRRK2, resulting in an increased propensity for the kinase domain to phosphorylate target substrates. The activation process can be modulated through various mechanisms, including altering the protein's GTPase activity, affecting protein-protein interactions, or influencing post-translational modifications. Consequently, LRRK2 activators are a valuable tool in laboratory research for dissecting the molecular pathways associated with LRRK2 function. Their discovery and study have opened up new avenues for investigating the role of LRRK2 in cellular physiology, particularly in the context of neurodegenerative diseases.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Nilotinib

641571-10-0sc-202245
sc-202245A
10 mg
25 mg
$209.00
$413.00
9
(1)

Nilotinib has been investigated for its potential to activate LRRK2 activity in Parkinson's disease research.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

Sunitinib has been explored for its potential to activate LRRK.